ROC methodology within a monitoring framework

Statistics in Medicine

Volumn 22, Issue 22, 2003, Pages 3473-3488

  Parker, Corette B ^a   DeLong, Elizabeth R ^b  

^a RTI INTERNATIONAL   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Cox regression; Diagnostic accuracy; Jack knife methods; Monitoring test; Partial likelihood; Receiver operating characteristic (ROC) curve

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CALCULATION; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DATA ANALYSIS; DIAGNOSTIC TEST; FIBRINOLYTIC THERAPY; FUNCTIONAL ASSESSMENT; HEART CATHETERIZATION; HEART MUSCLE REPERFUSION; HUMAN; INTERMETHOD COMPARISON; METHODOLOGY; PATIENT MONITORING; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; AREA UNDER CURVE; BIOLOGICAL MARKERS; DIAGNOSTIC TESTS, ROUTINE; FIBRINOLYTIC AGENTS; HUMANS; MONITORING, PHYSIOLOGIC; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; ROC CURVE; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 0242607934     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1580     Document Type: Article

References (17)

1. Hanley JA, McNeil BJ. Statistical approaches to the analysis of ROC curves. Medical Decision Making 1984; 4:137-150.
2. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44:837-845.
3. DeLong ER, Vernon WB, Bollinger RR. Sensitivity and specificity of a monitoring test. Biometrics 1985;41: 947-958.
4. Cox DR. Regression models and life-tables (with discussion). Journal of the Royal Statistical Society, Series B 1972: 34:187-220.
5. Cox DR. Partial likelihood. Biometrika 1975; 62:269-276.
6. Shao J, Tu D. The Jackknife and Bootstrap. Springer-Verlag: New York, 1995; 384.
7. Storer BE, Crowley J. A diagnostic for Cox regression and general conditional likelihoods. Journal of the American Statistical Association 1985; 80:139-147.
8. Parker CB, DeLong ER. A diagnostic for Cox regression with discrete failure-time models. Biometrics 2000; 56:996-1001.
9. Abendschein DR. Noninvasive screening for acute coronary syndromes. Coronary, Artery Disease 1999; 10(Review):67-68.
10. Newby LK, Kaplan AL, Granger BB, Sedor F, Califf RM, Ohman EM. Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit. American Journal of Cardiology 2000; 85:801-805.
11. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: is MB creatine kinase the choice for the 1990s? Circulation 1993; 88:750-763.
12. Cannon CP, McCabe CH, Diver DJ, Herson S, Greene RM, Shah PK, Sequeira RF, Leya F, Kirshenbaum JM, Magorien RD, Palmeri ST, Davis V, Gibson CM, Poole WK, Braunwald E and the TIMI 4 Investigators. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the thrombolysis in myocardial infarction (TIMI) 4 trial. Journal of the American College of Cardiology 1994; 24:1602-1610.
13. Abendschein DR, Puleo PR, Cannon CP and the TIMI IV and V Investigators. Noninvasive detection of early coronary artery patency based on plasma MM and MB creatine kinase (CK) isoforms. Circulation 1992; 86(Suppl. 1): 1-266 (abstract).
14. Ohman EM, Christenson RH, Califf RM, George BS, Samaha JK, Kereiakes DJ, Worley SJ, Wall TC, Berrios E, Sigmon KN, Lee K, Topol EJ and the TAMI 7 Study Group. Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. American Heart Journal 1993; 126:819-826.
15. Pepe MS, Thompson ML. Combining diagnostic test results to increase accuracy. Biostatistics 2000; 1: 123-140.
16. Hlatky MA, Boineau RE, Higginbotham MB, Lee KL, Mark DB, Califf RM, Cobb FR, Pryor DB. A brief self-administered questionnaire to determine functional capacity (the Duke activity status index). American Journal of Cardiology 1989; 64:651-654.
17. Emir B, Wieand S, Su JQ, Cha S. Analysis of repeated markers used to predict progression of cancer. Statistics in Medicine 1998; 17:2563-2578.